E-LIB Suche - Ergebnisse für: Parasrampuria, S.

1

EE42 Value of Being the First Biosimilar Entrant:

McGeeney, J.D. ; Sertkaya, A ; Parasrampuria, S...
Value in Health. 27 (2024) 6 - p. S64 , 2024

Link: https://doi.org/10.1016/..

2

HPR48 Comparing Out-of-Pocket Spending on Ultra-Expensive D..:

DiStefano, M.J. ; Kang, S.Y. ; Parasrampuria, S..
Value in Health. 26 (2023) 6 - p. S219 , 2023

Link: https://doi.org/10.1016/..

3

PSY128 - HOW LONG CAN THE ORPHAN DRUG EXCLUSIVITY PERIOD BE..:

Padula, W.V. ; Parasrampuria, S. ; Socal, M.P..
Value in Health. 21 (2018) - p. S458 , 2018

Link: https://doi.org/10.1016/..

4

Is the Orphan Drug Act Being used as a Loophole to Extend P..:

Padula, WV ; Parasrampuria, S ; Socal, M.
Value in Health. 21 (2018) - p. S89 , 2018

Link: https://doi.org/10.1016/..

5

Examining the Target Population of Orphan Drugs: Are Drugs ..:

Socal, MP ; Patel, P ; Parasrampuria, S..
Value in Health. 21 (2018) - p. S90 , 2018

Link: https://doi.org/10.1016/..

6

Role of Clinical Pharmacology in Diversity and Inclusion in..:

Sawant‐Basak, Aarti ; Urva, Shweta ; Mukker, Jatinder Kaur...
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

7

P2.06-06 Study Design to Assess Anti-TIGIT Mab Combination ..:

Spigel, D.R. ; Cho, B.C. ; Reck, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S319 , 2023

Link: https://doi.org/10.1016/..

8

Subcutaneous daratumumab in Asian patients with heavily pre..:

Iida, Shinsuke ; Ishikawa, Takayuki ; Min, Chang Ki...
Annals of Hematology. 100 (2021) 4 - p. 1065-1077 , 2021

Link: https://doi.org/10.1007/..

9

Safety and preliminary immunogenicity of JNJ-64041809, a li..:

Drake, Charles G. ; Pachynski, Russell K. ; Subudhi, Sumit K....
Prostate Cancer and Prostatic Diseases. 25 (2021) 2 - p. 219-228 , 2021

Link: https://doi.org/10.1038/..

10

Contributors:

, In: Cancer-Leading Proteases,

Adhikari, Nilanjan ; Ahir, Gouri ; Al-Dossary, Hanan A.... - p. xiii-xvi , 2020

Link: https://doi.org/10.1016/..

11

VALUE AND PERFORMANCE OF ACCOUNTABLE CARE ORGANIZATIONS: A ..:

Parasrampuria, Sonal ; Oakes, Allison H. ; Wu, Shannon S...
International Journal of Technology Assessment in Health Care. 34 (2018) 4 - p. 388-392 , 2018

Link: https://doi.org/10.1017/..

12

Contributors:

, In: Viral Proteases and Their Inhibitors,

Adhikari, Nilanjan ; Aggarwal, Megha ; Baidya, Sandip K.... - p. xi-xii , 2017

Link: https://doi.org/10.1016/..

13

The impact of a three-factor prothrombin complex concentrat..:

Brown, Karen S. ; Wickremasingha, Prachi ; Parasrampuria, Dolly A....
Thrombosis Research. 136 (2015) 4 - p. 825-831 , 2015

Link: https://doi.org/10.1016/..

14

PhaseIIstudy results of a replacement therapy for hereditar..:

Zuraw, B. L. ; Cicardi, M. ; Longhurst, H. J....
Allergy. 70 (2015) 10 - p. 1319-1328 , 2015

Link: https://doi.org/10.1111/..

15

Pharmacokinetics and Pharmacodynamics of the Nonvitamin K A..:

Parasrampuria, Dolly A. ; Weilert, Doris ; Maa, Jen-Fue...
Clinical Drug Investigation. 36 (2015) 2 - p. 127-136 , 2015

Link: https://doi.org/10.1007/..